Johnson Lau is the founder of Athenex. Athenex has raised $500M in total funding. Latest round: IPO. Based in Buffalo, United States.
Dr. Johnson Lau is the Chairman and CEO of Athenex, a pharmaceutical company focused on developing and manufacturing cancer drugs. He has led the company through significant capital raises, including over $500 million in total funding, and an IPO filing with the SEC.
Full founder directory · Investor directory · Company funding database · Fundraising library